Ilsung Pharm Cash Flow Reinvestment Rate
Ilsung Pharm cash flow reinvestment rate. Ilsung Pharm (003120) has a Cash Flow Reinvestment Rate of 74.14x as of June 2026, reinvesting ₩9.21 Billion (capex ₩731.07 Million plus investments ₩-8.48 Billion) from operating cash flow of ₩124.28 Million. Explore Ilsung Pharm (003120) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Ilsung Pharm (2013–2025)
Cash flow reinvestment rate of Ilsung Pharm from 2013 to 2025. Historical reinvestment intensity for Ilsung Pharm across 9 annual periods. Explore 003120 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Ilsung Pharm Cash Flow Reinvestment Rate by Year (2013–2025)
Ilsung Pharm cash flow reinvestment rate by year from 2013 to 2025. Year-by-year capital reinvestment analysis for Ilsung Pharm. For the full cash flow conversion analysis, see 003120 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.26x | ₩8.79 Billion | ₩3.88 Billion | ₩2.18 Billion | ▼ -59.9% |
| 2021 | 5.65x | ₩32.21 Billion | ₩5.70 Billion | ₩10.93 Billion | ▲ +25.1% |
| 2020 | 4.52x | ₩7.03 Billion | ₩1.56 Billion | ₩4.82 Billion | ▼ -11.7% |
| 2019 | 5.11x | ₩22.44 Billion | ₩4.39 Billion | ₩1.24 Billion | ▲ +540.5% |
| 2018 | 0.80x | ₩12.05 Billion | ₩15.09 Billion | ₩1.21 Billion | ▲ +96.7% |
| 2017 | 0.41x | ₩4.12 Billion | ₩10.16 Billion | ₩1.85 Billion | ▼ -58.5% |
| 2015 | 0.98x | ₩5.91 Billion | ₩6.04 Billion | ₩2.85 Billion | ▼ -37.6% |
| 2014 | 1.57x | ₩6.57 Billion | ₩4.19 Billion | ₩945.31 Million | ▲ +222.5% |
| 2013 | 0.49x | ₩2.46 Billion | ₩5.06 Billion | ₩1.13 Billion | — |